CAS 1314891-22-9

N-[2-Methyl-2-(2-phenyl-4-oxazolyl)propyl]-3-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide

CAS: 1314891-22-9

Formel: C₂₃H₁₉F₃N₄O₃

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 456.4172

Ref: IN-DA00A1H2

TMP195

CAS: 1314891-22-9

TMP195

Reinheit: ≥98%

Molekulargewicht: 456.42g/mol

Ref: 54-BUP10089

TMP195

CAS: 1314891-22-9

TMP195 (TFMO 2) is a selective class IIa histone deacetylase (HDAC) inhibitor.

Formel: C₂₃H₁₉F₃N₄O₃

Reinheit: 98.92% - 99.64%

Farbe und Form: Solid

Molekulargewicht: 456.42

Ref: TM-T3983

TMP 195

CAS: 1314891-22-9

Formel: C₂₃H₁₉F₃N₄O₃

Molekulargewicht: 456.14

Ref: 4Z-K-031134

N-[2-Methyl-2-(2-phenyloxazol-4-yl)propyl]-3-[5-(trifluoroMethyl)-1,2,4-oxadiazol-3-yl]benzaMide

CAS: 1314891-22-9

Reinheit: 98%

Molekulargewicht: 456.4249878

Ref: 10-F866438

TMP195

CAS: 1314891-22-9

TMP195 is a small molecule that inhibits the acetylation of histone H3 at lysine 9 (H3K9) and histone H4 at lysine 12 (H4K12). TMP195 has been shown to reduce the growth of metastatic colorectal cancer cells in vivo. It also inhibits tumor growth by decreasing the expression of colony-stimulating factor, which is involved in cell proliferation and differentiation. TMP195 may be used as a therapeutic agent for the treatment of cancers such as breast, lung, prostate, colon, and pancreas.

Formel: C₂₃H₁₉F₃N₄O₃

Reinheit: Min. 95%

Molekulargewicht: 456.42 g/mol

Ref: 3D-PCC89122